Literature DB >> 3508547

Computer-aided dosage form design. II. Methods for defining a zero-order sustained-release delivery system of maximum formulating flexibility.

T Y Lee1, R E Notari.   

Abstract

Classical methods employing pharmacokinetic data to calculate zero-order release rates for sustained release products require that a constant-rate drug delivery system must have a duration which is exactly equal to the desired dosage interval. This traditional approach fails to establish the minimum acceptable duration and also fails to provide any flexibility in the formulation goal. While it does calculate one pair of duration and dose values, there are infinite pairs of values capable of maintaining the desired plasma concentrations using the selected dosing interval. In the current method, computer simulations are used to establish the boundary conditions within which any pair of duration and dose values will maintain the desired levels when administered on the chosen dosing interval. By comparing the boundary conditions for every subject in a group, a single set of conditions which would work for the entire group can be selected. These final limits represent the broadest specifications for zero-order drug delivery system design for that particular drug combined with the plasma concentration goals and the desired dosing interval. The method is illustrated using theophylline pharmacokinetics.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3508547     DOI: 10.1023/a:1016478127409

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Influence of diet and fluid on bioavailability of theophylline.

Authors:  P G Welling; L L Lyons; W A Craig; G A Trochta
Journal:  Clin Pharmacol Ther       Date:  1975-04       Impact factor: 6.875

2.  Blood levels from a sustained-release dosage form.

Authors:  M R Dobrinska; P G Welling
Journal:  J Pharm Sci       Date:  1975-10       Impact factor: 3.534

3.  MATHEMATICAL TREATMENT OF ORAL SUSTAINED RELEASE DRUG FORMULATIONS.

Authors:  M ROWLAND; A H BECKETT
Journal:  J Pharm Pharmacol       Date:  1964-12       Impact factor: 3.765

4.  Theoretical approach to sustained-release multiple-dose therapy: noncumulative attainment of desired blood level.

Authors:  J R Robinson; S P Eriksen
Journal:  J Pharm Sci       Date:  1970-12       Impact factor: 3.534

5.  A cross-over study of oral and intravenous administration of theophylline in male volunteers. Absolute bioavailability of theophylline tablets.

Authors:  H S Kaumeier; O H Kehrhahn; G Neugebauer; D Schuppan; J A Schwarz; A H Staib
Journal:  Arzneimittelforschung       Date:  1984

6.  Theoretical formulation of sustained-release dosage forms.

Authors:  J R Robinson; S P Eriksen
Journal:  J Pharm Sci       Date:  1966-11       Impact factor: 3.534

7.  Theophylline bioavailability following oral administration of six sustained-release preparations.

Authors:  D L Spangler; D D Kalof; F L Bloom; H J Wittig
Journal:  Ann Allergy       Date:  1978-01

8.  Pharmacokinetics and dose regimen of oral theophylline in children.

Authors:  P Bolme; M Eriksson; G Lönnerholm; L Paalzow
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1982-11

9.  Pharmacokinetic analysis of the disposition of intravenous theophylline in young children.

Authors:  P M Loughnan; D S Sitar; R I Ogilvie; A Eisen; Z Fox; A H Neims
Journal:  J Pediatr       Date:  1976-05       Impact factor: 4.406

10.  Computer-aided dosage form design. I. Methods for defining a long-acting first-order delivery system of maximum formulating flexibility.

Authors:  T Y Lee; R E Notari
Journal:  Pharm Res       Date:  1987-08       Impact factor: 4.200

View more
  1 in total

1.  Computer-aided dosage form design. III. Feasibility assessment for an oral prolonged-release phenytoin product.

Authors:  J R Irvin; R E Notari
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.